NTRK2 and craniodiaphyseal dysplasia: While application of a TrkB agonist has been shown to rescue both functional and structural impairments in the perirhinal cortex of Cdkl5-/y mice [23], little is known about the role of BDNF in the pathology of CDD in contrast to RTT.